Artmarket.com: Double-digit growth in Q2 2025, Revolutionary Artprice-Perplexity AI rapprochement: The Mixed Subscription for the Second Half of 2025/2026 Will Redefine the Intelligence of the Art Market
PARIS, Aug. 7, 2025 /PRNewswire/ -- The Board of Directors, its founding…
Art of Time: A Decade of Horological Excellence
Art of Time celebrates a decade of shaping India's luxury watch landscape…
Automobili Lamborghini captivates Sylt: performance meets art
An exclusive showcase of Italian super sports cars, design and lifestyle at…
ART COMES TO LIFE AT RUNWAL RAAYA IN WORLI WITH TAO ART GALLERY COLLAB
MUMBAI, India, July 16, 2025 /PRNewswire/ -- Runwal Realty, one of India's most…
Art Never Melts: Huion’s Prime Day 2025 Cool Creative Deals
LOS ANGELES, July 8, 2025 /PRNewswire/ -- When the cruel summer heat meets…
Runwal Raaya Hosts an Immersive Evening with Tao Art Gallery
Runwal Raaya transforms into a canvas for contemporary Indian artBollywood's Neha Dhupia…
“The Most Important Thing About Art is Freedom,” says AR Rahman at IGF London 2025
Oscar-winning composer on scent cinema, AI, and the reinvention of Indian music…
“AI and the Art Market” by Arte, with Artprice by Artmarket and analysis by Perplexity.AI Labs
PARIS, June 16, 2025 /PRNewswire/ -- This Sunday, June 15th, 2025, the…
![[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients](https://i1.wp.com/ml-eu.globenewswire.com/media/NTJlMDkyZjktNGMwNi00N2YyLTkyZmQtZTIwMWJlNzgxOWYyLTEwMTI2MjEtMjAyNS0wNi0xNS1lbg==/tiny/F-Hoffmann-La-Roche-Ltd.png?w=420&resize=420,280&ssl=1 "[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients")
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients
After a thorough clinical review, the benefit-risk for the use of Elevidys…
IPSEN – Buy-back programme – Art 5 of MAR – Week 23 – 2025
Aggregated presentation by day and by market Statement of transactions in own…
